Abstract
Background Emerging evidence indicates a potential role for monocyte in COVID-19 immunopathology. We investigated two soluble markers of monocyte activation, sCD14 and sCD163, in covid19 patients with the aim of characterizing their potential role in monocyte-macrophage disease immunopathology. To the best of our knowledge, this is the first study of its kind.
Methods Fifty-nine SARS-Cov-2 positive hospitalized patients, classified according to ICU or non-ICU admission requirement, were prospectively recruited and analyzed by ELISA for levels of sCD14 and sCD163, along with other laboratory parameters, and compared to a healthy control group.
Results sCD14 and sCD163 levels were significantly higher among COVID-19 patients, independently of ICU admission requirement, compared to the control group. We found a significant correlation between sCD14 levels and other inflammatory markers, particularly Interleukin-6, in the non-ICU patients’ group. sCD163 showed a moderate positive correlation with the time at sampling from admission, increasing its value over time, independently of severity group.
Conclusions Monocyte-macrophage activation markers are increased and correlate with other inflammatory markers in SARS-Cov-2 infection, in association to hospital admission. These data suggest a potentially preponderant role for monocyte-macrophage activation in the development of immunopathology of covid19 patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study received support from the Instituto de Salud Carlos III: project GePEM (Instituto de Salud Carlos III(ISCIII)/PI16/01478/Cofinanciado FEDER), DIAVIR (Instituto de Salud Carlos III(ISCIII)/DTS19/00049/Cofinanciado FEDER; Proyecto de Desarrollo Tecnologico en Salud) and Resvi-Omics (Instituto de Salud Carlos III(ISCIII)/PI19/01039/Cofinanciado FEDER) and project BI-BACVIR (PRIS-3; Agencia de Conocimiento en Salud (ACIS) Servicio Gallego de Salud (SERGAS) Xunta de Galicia; Spain) given to A.S.; and projects ReSVinext (Instituto de Salud Carlos III(ISCIII)/PI16/01569/Cofinanciado FEDER), and Enterogen (Instituto de Salud Carlos III(ISCIII)/ PI19/01090/Cofinanciado FEDER) given to F.M.-T.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained for this project by the Ethic Committee of Galicia. All samples were obtained after obtention of pertinent informed consent.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵9 GEN-COVID Study Group (www.gencovid.es):
Aguilera Guirao, Antonio3; Álvarez Escudero, Julián7; Antela López, Antonio5; Barbeito Castiñeiras, Gema3; Bello Paderne, Xabier1; Ben García, Miriam1; Carral García, María Victoria12; Cebey López, Miriam1; Coira Nieto, Amparo3; Conde Pájaro, Mónica9; Costa Alcalde, José Javier3; Currás Tuala, María José1; Dacosta Urbieta, Ana Isabel1; Díaz Esteban, Blanca1; Domínguez Santalla, María Jesús5; Fernández Villaverde, Juan6; Galbán Rodríguez, Cristóbal6; García Allut, José Luis6; García Vicente, Luisa1; Giráldez Vázquez, Elena6; Gómez Carballa, Alberto1; Gómez Rial, José1; González Barcala, Francisco Javier4; Guerra Liñares, Beatriz9; Leboráns Iglesias, Pilar1; Lence Massa, Beatriz6; Lendoiro Fuentes, Marta1; López Franco, Montserrat1; López Lago, Ana6; Navarro De la Cruz, Daniel3; Núñez Masid, Eloína10; Ortolá Devesa, Juan Bautista8; Pardo Seco, Jacobo1; Pazo Núñez, María5; Pérez del Molino Bernal, Marisa3; Pérez Freixo, Hugo9; Piñeiro Rodríguez, Lidia1; Pischedda, Sara1; Portela Romero, Manuel11; Pose Reino, Antonio5; Prada Hervella, Gloria María7; Queiro Verdes, Teresa9; Redondo Collazo, Lorenzo1; Regueiro Casuso, Patricia1; Rey García, Susana1; Rey Vázquez, Sara1; Riveiro Blanco, Vanessa4; Rivero Calle, Irene1; Rivero Velasco, Carmen6; Rodríguez Núñez, Nuria4; Rodríguez-Tenreiro Sánchez, Carmen1; Saborido Paz, Eva6; Sadiki Orayyou, José Miguel1; Saito Villanueva, Carla6; Serén Fernández, Sonia1; Souto Sanmartín, Pablo9; Taboada Muñiz, Manuel7; Trastoy Pena, Rocío3; Treviño Castellano, Mercedes3; Valdés Cuadrado, Luis4; Varela García, Pablo5; Vilas Iglesias, María Soledad1; Viz Lasheras, Sandra1.
1 Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain, and GENVIP Research Group (www.genvip.org), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela, Galicia, Spain.
2 Unidade de Xenética, Departamento de Anatomía Patolóxica e Ciencias Forenses, Instituto de Ciencias Forenses, Facultade de Medicina, Universidade de Santiago de Compostela, and GenPop Research Group, Instituto de Investigaciones Sanitarias (IDIS), Hospital Clínico Universitario de Santiago, Galicia, Spain.
3 Microbiology Service, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Galicia, Spain
4 Pneumology Service, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Galicia, Spain
5 Internal Medicine Service, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Galicia, Spain
6 Intensive Care Service, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Galicia, Spain
7 Anesthesiology and Resuscitation Service, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Galicia, Spain
8 Clinical Chemistry Laboratory, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Galicia, Spain
9 Preventive Medicine Unit, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Galicia, Spain
10 Manager of the Health Care Area of Santiago de Compostela and Barbanza, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Galicia, Spain
11 Deputy Director of Pharmaceutical Delivery, Training, Teaching, Research and Innovation, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Galicia, Spain
12 Director of Nursing Processes, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Galicia, Spain
Data Availability
All data referred to this manuscript are available upon request